LIVE: President Trump participates in a health care affordability event at the White House — 4/23/26

Summary

President Trump hosts a health care affordability event at the White House, announcing that 17 major pharmaceutical companies have agreed to most-favored-nation pricing, leading to historic drug price cuts. The event also features the FDA approval of Regeneron's gene therapy for deafness, which will be given free to children for a period. Later, in a Q&A, Trump discusses the military campaign against Iran, the stock market's resilience, and the rescheduling of medical marijuana to Schedule III.

• Trump announces that 17 pharma companies representing 80% of the branded drug market have agreed to most-favored-nation pricing, cutting drug prices significantly.
• Regeneron commits to offering all new drugs at MFN prices and will provide its gene therapy for deafness (Oarmony) free to children.
• The FDA approves Regeneron's gene therapy for a rare form of deafness; a 2-year-old boy treated with it can now hear.
• Trump claims the stock market is at an all-time high despite the Iran conflict, and oil prices have not surged as feared.
• The administration announces the rescheduling of state-licensed medical marijuana products to Schedule III to facilitate research.
• Trump defends the timeline of the Iran military operation, saying the Iranian military has been largely destroyed.
• Commerce Secretary Lutnik confirms $448 billion in drug manufacturing reshoring commitments from pharma companies due to tariffs.
• Trump discusses a cost-effective renovation of the Lincoln Memorial Reflecting Pool, contrasting it with previous expensive government bids.